Collaborative preclinical efficacy studies suggest a new target for drug addiction treatment
In preclinical studies, researchers at SRI International and Astraea Therapeutics have recently evaluated the role of a new drug receptor target that shows promise for the treatment of drug addiction.
Mar 14, 2012
0
0